Results of an autologous noncryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: A single-institution, 10-year experience

Acta Haematologica

Volumn 110, Issue 4, 2003, Pages 179-183

  Ruiz Argüelles, Guillermo J ^a,b   Gómez Rangel, David ^a,b   Ruiz Delgado, Guillermo J ^c   Ruiz Argüelles, Alejandro ^c   Pérez Romano, Beatriz ^b   Rivadeneyra, Liliana ^b  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Autotransplants; Outpatient; Peripheral blood; Stem cells

Indexed keywords

ANTINEOPLASTIC AGENT; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; BREAST CARCINOMA; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRYOPRESERVATION; DEVELOPING COUNTRY; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; GRANULOCYTE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OUTPATIENT; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; CRYOPRESERVATION; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 0345600203     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074221     Document Type: Article

References (29)

1. Körbling M, Champlin R: Peripheral blood progenitor cell transplantation: A replacement for marrow auto- or allografts. Stem Cells 1996;14:185-195.
2. Cirenza E: Peripheral blood progenitor cells: Mobilization and transplantation; in Smith DM, Sacher RA (eds): Peripheral Blood Stem Cells. Bethesda, American Association of Blood Banks, 1993, pp 45-64.
3. Sheridan WP, Begley CG, Juttner CA, Szer J, Bik To L, Maher D, McGrath KM, Mortsyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992;339:640-644.
4. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Alemán-Hoey DD, Arizpe-Bravo D, Marín-López A, Ocejo-Rodríguez A: Autotrasplante en leucemia aguda de células totipotenciales movilizadas con filgrastim. Rev Invest Clín Méx 1993;45:479-480.
5. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Larregina-Díez A, Apreza-Molina MG: Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995;48:100-103.
6. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Delgado-Lamas JL: Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis. Am J Hematol 1998;58:161-164.
7. Ruiz-Argüelles GJ, Lobato-Mendizábal E, Ruiz-Argüelles A, Pérez-Romano B, Arizpe-Bravo D, Marín-López A: Non-cryopreserved unmanipulated hematopoietic peripheral blood stem cell autotransplant program: Long-term results. Arch Med Res 1999;30:380-384.
8. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD: Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood 1988;71:723-727.
9. Ruiz-Argüelles A: Flow cytometry in the clinical laboratory. Principles, applications and problems. Ann Biol Clin 1992;50:735-743.
10. Ruiz-Argüelles A, Orfao A: Caracterización y evaluación de células totipotenciales en sangre periférica y médula ósea; in Ruiz-Argüelles GJ, San-Miguel JF (eds): Actualización en Leucemias. México City, Editorial Médica Panamericana, 1996, pp 79-82.
11. Kaplan EL, Meier P: Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457-463.
12. Ruiz-Argüelles GJ, López-Martínez B, López-Ariza B: Successful allogeneic stem cell transplantation with non-myeloablative conditioning in patients with relapsed Hodgkin's disease following autologous stem cell transplantion. Arch Med Res 2003;34:242-245.
13. Ruiz-Argüelles GJ: Outpatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation. Haematologica 2000;85:1233-1234.
14. Gómez-Almaguer D: The simplification of the stem cell transplantation procedures in developing countries has resulted in cost lowering and availability to more patients. Int J Hematol 2002;76(suppl 1):380-382.
15. Peters WP, Ross M, Vredenburgh JJ, Hussein A, Rubin P, Dukelow K, Cavanaugh C, Beauvais S, Kasprzak S: The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Semin Oncol 1994;21(suppl 1):25-31.
16. Carey PJ, Proctor SJ, Taylor P, Hamilton PJ: Autologous bone marrow transplantation for high-grade lymphoid malignancy using mel-phalan/irradiation conditioning without marrow purging or cryopreservation. Blood 1991;77:1593-1598.
17. Köpler H, Pfluger KH, Havemann K: Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescue. Ann Hematol 1991;63:253-258.
18. Lakshman V, Visweshwar J, Nimmagadda RBV, Ranjan M: Autologous and allogeneic peripheral blood stem cell transplants without manipulation nor cryopreservation in a developing country (India). Int J Hematol 1996; 64(suppl 1):s154.
19. Lekhakula A, Thamprasit T, Wiboonjantra P, Pornpatkul M, Maipang T: Non-cryopreserved peripheral blood progenitor cells for autologous transplantation. Int J Hematol 1996;64(suppl 1):s155.
20. Sobrevilla-Calvo P, Acosta-Barreda A, Dueñas A, Martínez J, Reynoso E: Autologous transplantation of 8 days non-cryopreserved peripheral blood stem cells mobilized with G-CSF: Description of a simple and effective method of hematologic support after intensive chemotherapy (abstract). ASCO Proc 1993;12:472
21. Feremans WW, Bastin G, Le Moine F, et al: Simplification of the blood stem cell transplantation procedure: Large volume apheresis and uncontrolled rate cryopreservation at -80°C. Eur J Haematol 1996;55:278-282.
22. Ossenkoppele GJ, Schuurhuis GJ, Jonkhoff AR, van der Hem KG, Legdeur MC, Boot-Bakker A, Westra AH, Drager AM, Huijgens PC: High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myeloma. Eur J Cancer 1996;32:2058-2063.
23. Thomas ED: Hematopoietic stem cell transplantation. Sci Am 1995;272:38-47.
24. Medical College of Wisconsin: Autologous Bone and Marrow Transplant Registry (ABMTR) Newsletter, December 1998, pp 7-10.
25. Ruiz-Argüelles GJ, Bruno GV: Trasplante de células totipotenciales hematopoyéticas; in Castellanos-Coutiño J (guest ed): Temas de Medicina Interna: Trasplante de órganos. Asociación de Medicina Interna de México. México, McGraw-Hill/Interamericana, 1998, pp 85-99.
26. Armitage JO: Bone marrow transplantation. N Engl J Med 1994;330:827-838.
27. Ruiz-Argüelles GJ, López-Martínez B, Ramírez-Cabrera JM, Reyes-Nuñez V, Rodríguez-Cedeño H, Garcés-Eisele J: Molecular monitoring of the treatment of patients with BCR/ ABL(+) chronic myelogenous leukemia. Rev Invest Clín Méx 2001;53:235-239.
28. Ruiz-Arguelles GJ: What is the dose of STI-571 needed to induce a molecular remission in chronic myeloid leukemia? Haematologica 2002;87:ELT15.
29. Delgado-Lamas JL, Garcés-Ruiz OM, Rubio-Jurado B: Trasplante de células hematopoyéticas. Experiencia del Centro Médico Nacional de Occidente. Rev Invest Clin Méx 2000;52:234-240.